ADVerse outcome Network for non-mutagenic CarcinogEns

Project Information

ADVaNCE

Grant agreement ID: 750195

DOI 10.3030/750195

Project closed

EC signature date 4 September 2017

Start date 1 October 2017

End date 30 September 2019

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost € 187 419,60

EU contribution € 187 419,60

Coordinated by

EDELWEISS CONNECT GMBH
Switzerland

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (2)

Integrated analysis of in vitro data and the adverse outcome pathway framework for prioritization and regulatory applications: An exploratory case study using publicly available data on piperonyl butoxide and liver models

Author(s): Noffisat O. Oki, Lucian Farcal, Ahmed Abdelaziz, Oana Florean, Tatyana Y. Doktorova, Thomas Exner, Pekka Kohonen, Roland Grafström, Barry Hardy
Published in: Toxicology in Vitro, Issue 54, 2019, Page(s) 23-32, ISSN 0887-2333
Publisher: Elsevier BV
DOI: 10.1016/j.tiv.2018.09.002

An automated workflow for Adverse Outcome Pathway hypothesis generation: the use case of non-genotoxic induced hepatocellular carcinoma

Author(s): Tatyana Y. Doktorova, Noffisat O. Oki, Tomaž Mohorič, Thomas E. Exner, Barry Hardy
Published in: Regulatory Toxicology and Pharmacology, Issue (submitted), 2019, ISSN 0273-2300
Publisher: Academic Press

Conference proceedings (1)

Use of publicly available transcriptomics data to support the steatosis AOP development

Author(s): Oana Florean, Lucian Farcal, Noffisat Oki, Thomas Exner, Barry Hardy and Tatyana Doktorova
Published in: 2018, ISSN 1868-596X
Publisher: Altex